Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)

Abstract Background Studies showed that axillary lymph node dissection can be safely omitted in presence of positive sentinel lymph node(s) in breast cancer patients treated with breast conserving therapy. Since the outcome of the sentinel lymph node biopsy has no clinical consequence, the value of the procedure itself is being questioned. The aim of the BOOG 2013–08 trial is to investigate whether the sentinel lymph node biopsy can be safely omitted in clinically node negative breast cancer patients treated with breast conserving therapy. Methods The BOOG 2013–08 is a Dutch prospective non-in... Mehr ...

Verfasser: L. M. van Roozendaal
M. L. G. Vane
T. van Dalen
J. A. van der Hage
L. J. A. Strobbe
L. J. Boersma
S. C. Linn
M. B. I. Lobbes
P. M. P. Poortmans
V. C. G. Tjan-Heijnen
K. K. B. T. Van de Vijver
J. de Vries
A. H. Westenberg
A. G. H. Kessels
J. H. W. de Wilt
M. L. Smidt
Dokumenttyp: Artikel
Erscheinungsdatum: 2017
Reihe/Periodikum: BMC Cancer, Vol 17, Iss 1, Pp 1-8 (2017)
Verlag/Hrsg.: BMC
Schlagwörter: Breast neoplasms / Breast cancer / Sentinel lymph node biopsy / Breast conserving therapy / Neoplasms. Tumors. Oncology. Including cancer and carcinogens / RC254-282
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26626961
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1186/s12885-017-3443-x